JP2002171966A5 - - Google Patents

Download PDF

Info

Publication number
JP2002171966A5
JP2002171966A5 JP2000368287A JP2000368287A JP2002171966A5 JP 2002171966 A5 JP2002171966 A5 JP 2002171966A5 JP 2000368287 A JP2000368287 A JP 2000368287A JP 2000368287 A JP2000368287 A JP 2000368287A JP 2002171966 A5 JP2002171966 A5 JP 2002171966A5
Authority
JP
Japan
Prior art keywords
cord blood
interleukin
antibody
derived
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000368287A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002171966A (ja
JP4917201B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2000368287A priority Critical patent/JP4917201B2/ja
Priority claimed from JP2000368287A external-priority patent/JP4917201B2/ja
Priority to EP01310091A priority patent/EP1211311A3/en
Priority to CN01140404A priority patent/CN1363681A/zh
Priority to US10/003,539 priority patent/US6692958B2/en
Publication of JP2002171966A publication Critical patent/JP2002171966A/ja
Publication of JP2002171966A5 publication Critical patent/JP2002171966A5/ja
Application granted granted Critical
Publication of JP4917201B2 publication Critical patent/JP4917201B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000368287A 2000-12-04 2000-12-04 臍帯血移植後の腫瘍および各種感染症の予防・治療用製剤、臍帯血移植後の移植臍帯血幹細胞の生着促進用製剤、臍帯血移植後の腫瘍および各種感染症の予防・治療用製剤ならびに臍帯血移植後の移植臍帯血幹細胞の生着促進用製剤の製造方法。 Expired - Fee Related JP4917201B2 (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2000368287A JP4917201B2 (ja) 2000-12-04 2000-12-04 臍帯血移植後の腫瘍および各種感染症の予防・治療用製剤、臍帯血移植後の移植臍帯血幹細胞の生着促進用製剤、臍帯血移植後の腫瘍および各種感染症の予防・治療用製剤ならびに臍帯血移植後の移植臍帯血幹細胞の生着促進用製剤の製造方法。
EP01310091A EP1211311A3 (en) 2000-12-04 2001-12-03 Cord blood-derived activated lymphocytes and preparations containing said lymphocytes
CN01140404A CN1363681A (zh) 2000-12-04 2001-12-04 源于脐带血的活化淋巴细胞、含有所述淋巴细胞作为主要成分的制剂和制备所述制剂的方法与成套器具
US10/003,539 US6692958B2 (en) 2000-12-04 2001-12-04 Cord blood-derived activated lymphocytes, preparations containing said lymphocytes as main ingredient and method and kit for producing said preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000368287A JP4917201B2 (ja) 2000-12-04 2000-12-04 臍帯血移植後の腫瘍および各種感染症の予防・治療用製剤、臍帯血移植後の移植臍帯血幹細胞の生着促進用製剤、臍帯血移植後の腫瘍および各種感染症の予防・治療用製剤ならびに臍帯血移植後の移植臍帯血幹細胞の生着促進用製剤の製造方法。

Publications (3)

Publication Number Publication Date
JP2002171966A JP2002171966A (ja) 2002-06-18
JP2002171966A5 true JP2002171966A5 (https=) 2008-01-17
JP4917201B2 JP4917201B2 (ja) 2012-04-18

Family

ID=18838567

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000368287A Expired - Fee Related JP4917201B2 (ja) 2000-12-04 2000-12-04 臍帯血移植後の腫瘍および各種感染症の予防・治療用製剤、臍帯血移植後の移植臍帯血幹細胞の生着促進用製剤、臍帯血移植後の腫瘍および各種感染症の予防・治療用製剤ならびに臍帯血移植後の移植臍帯血幹細胞の生着促進用製剤の製造方法。

Country Status (4)

Country Link
US (1) US6692958B2 (https=)
EP (1) EP1211311A3 (https=)
JP (1) JP4917201B2 (https=)
CN (1) CN1363681A (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7572631B2 (en) 2000-02-24 2009-08-11 Invitrogen Corporation Activation and expansion of T cells
JP4562353B2 (ja) * 2002-04-08 2010-10-13 株式会社リンフォテック Ｈｌａ一致他人由来活性化リンパ球を含有してなる腫瘍・感染症および自己免疫疾患の予防・治療用製剤
US20070025961A1 (en) * 2003-06-03 2007-02-01 Kenzo Bamba Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survival of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transf
JP2007528734A (ja) 2004-03-12 2007-10-18 エクセリクシス， インク． Ｉｇｆｒ経路のモディファイヤーとしてのｐｄｅ及び使用方法
WO2006086716A2 (en) * 2005-02-10 2006-08-17 Xcyte Therapies, Inc. Donor lymphocyte infusion of activated t cells for the treatment of cancer
JP2007055906A (ja) * 2005-08-22 2007-03-08 Lymphotec:Kk 腫瘍犬の治療法、その治療用製剤、腫瘍犬治療用細胞の凍結保存方法
CA2659697A1 (en) * 2006-08-01 2008-02-07 Arigen Pharmaceuticals, Inc. Method of proliferating lak cell
JP5596007B2 (ja) * 2011-12-09 2014-09-24 保幸 黒岩 細胞培養方法および培養装置
JP6142142B2 (ja) * 2012-04-10 2017-06-07 株式会社リンフォテック メモリーｔ細胞を主成分とするリンパ球細胞群の製造方法
CN113952475B (zh) * 2021-09-27 2025-03-11 中国人民解放军陆军军医大学 淋巴细胞和介导crispr系统的纳米复合物联合在制备治疗宫颈癌药物中的应用
CN114438027A (zh) * 2022-02-28 2022-05-06 浙江卫未生物医药科技有限公司 一种脐带血淋巴细胞制剂的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1001034B (el) * 1989-07-21 1993-03-31 Ortho Pharma Corp Μεθοδος διεγερσης του πολλαπλασιασμου λεμφοκυτταρων περιφερειακου αιματος.
IL112969A (en) * 1994-03-17 2001-05-20 Baxter Int Pharmaceutical compositions for the treatment of cancer comprising allogenic lymphocytes or their combination with a t-cell activator
US5773224A (en) * 1996-02-12 1998-06-30 Grandics; Peter Immunoselection system for cell elution
DE69738997D1 (de) * 1996-07-15 2008-10-30 Lymphotec Inc Mittel zur heilung bzw. vorbeugung viraler infektionen, verfahren zu deren herstellung sowie verfahren zur vorbeugung bzw. heilung viraler infektionen
JP4389039B2 (ja) * 1998-04-09 2009-12-24 株式会社リンフォテック アロジェニックな活性化ｃｄ４陽性細胞を主成分とする医薬組成物、およびその製造方法、ならびに該医薬組成物調製用キット

Similar Documents

Publication Publication Date Title
JP2002506831A5 (https=)
JP2004506598A5 (https=)
JP2002171966A5 (https=)
JP2002501748A5 (https=)
NZ597965A (en) Methods of preparing and using stem cell compositions and kits comprising the same
CN106967674B (zh) 一种绵羊瘤胃上皮细胞的分离培养方法
JP2001524307A5 (https=)
PL367617A1 (en) Antigen presenting cells, method for their preparation and their use for cancer vaccines
WO2002064748A3 (en) Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
WO2005011569A3 (en) Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
CN104830756A (zh) 翘嘴红鲌精原干细胞分离培养方法
CN108004209A (zh) 一种脐血调节性t细胞体外扩增方法
EP1476540A1 (fr) Procedes de production de lymphocytes gamma delta t
JP2005519591A5 (https=)
CN109646458B (zh) 使用胎盘间充质干细胞制剂治疗硬化病的方法
CN109182263A (zh) 一种用茶皂素溶解月经血红细胞分离宫膜间充质干细胞的方法
AU645488B2 (en) A process for the generation of proliferating CD4 lymphocytes
JP2002528115A5 (https=)
EP1211311A3 (en) Cord blood-derived activated lymphocytes and preparations containing said lymphocytes
JP2009517078A5 (https=)
EP3031470A3 (en) Manipulation of regulatory t cell and dc function by targeting neuritin gene using antibodies, agonists and antagonists
EP0953351A3 (en) Medicaments containing, as the main ingredient, allogenic activated-CD4+ cells and method for producing the same
DE60329226D1 (de) Verfahren zur unterdrückung einer immunsystemreaktion gegen gewebe- oder zelltransplantate
CN104371970B (zh) 一种用于培养人羊膜上皮细胞的培养基
Schuler et al. Production and properties of large numbers of dendritic cells from human blood